Clinical TrialsSearch results
Number of results: 201
Other
- A Randomized Phase III trial of chemotherapy alone versus chemotherapy followed by gefitinib in stage IIIB/IV non-small cell lung cancer
- Stage IIIB/IV Non-small cell lung cancer
- West Japan Thoracic Oncology Group (WJTOG)
- 2005-09-04
Other
- Investigation of the Optimal Treatment Strategy for Atrial Fibrillation in Japan -The J-RHYTHM (Japanese Rhythm Management Trial for Atrial Fibrillation) Study-
- Atrial Fibrillation
- The J-RHYTHM Investigators
- 2005-09-08
Other
- Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) Study: Prospective Randomized Open-label Blinded Endpoint (PROBE)
- Untreated essential hypertensive patients
- HOMED-BP Study Group
- 2005-09-09
Other
- Phase II study of gefitinib in patients with EGFR mutation positive- advanced non-small cell lung cancer
- non-small cell lung cancer
- West Japan Oncology Group
- 2005-09-09
Other
- Study of imatinib monotherapy and combination of imatinib with IFN or cytarabine ocfosfate for chronic-phase CML (JALSG CML202 Study)
- Previously untreated chronic-phase chronic myelogenous leukemia
- Japan Adult Leukemia Study Group
- 2005-09-10
Other
- Phase II study of irinotecan and amrubicin for relapsed non-small-cell lung cancer
- Relapsed non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12
Other
- Phase II study of topotecan and amrubicin for metastatic or relapsed small-cell lung cancer
- Metastatic or relapsed small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12
Other
- Phase II study of topotecan and cisplatin for elderly small-cell lung cancer
- Elderly small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12
Other
- Randomized phase II trial of S-1 plus docetaxel combination versus single-agent docetaxel in platinum-pretreated patients with non-small-cell lung cancer
- platinum-pretreated patients with non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12
Other
- Randomized, comparative clinical study of cisplatin and docetaxel combination chemotherapy and mitomycin, vindesine and cisplatin (MVP) combination chemotherapy with concurrent thoracic radiation therapy for locally advanced unresectable non-small-cell lung cancer (OLCSG0007)
- inoperable locally advanced non-small-cell lung cancer
- Okayama Lung Cancer Study Group (OLCSG)
- 2005-09-12